Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Net Margin (2017 - 2019)

Historic Net Margin for Iterum Therapeutics (ITRM) over the last 3 years, with Q1 2019 value amounting to 55621.62%.

  • Iterum Therapeutics' Net Margin fell 492624600.0% to 55621.62% in Q1 2019 from the same period last year, while for Dec 2019 it was 278729.73%, marking a year-over-year decrease of 2698625300.0%. This contributed to the annual value of 748.23% for FY2024, which is 4698900.0% down from last year.
  • As of Q1 2019, Iterum Therapeutics' Net Margin stood at 55621.62%, which was down 492624600.0% from 10149.79% recorded in Q4 2018.
  • In the past 5 years, Iterum Therapeutics' Net Margin ranged from a high of 2612.61% in Q4 2017 and a low of 55621.62% during Q1 2019
  • For the 3-year period, Iterum Therapeutics' Net Margin averaged around 14028.46%, with its median value being 8511.89% (2018).
  • Its Net Margin has fluctuated over the past 5 years, first crashed by -46661200bps in 2018, then crashed by -492624600bps in 2019.
  • Iterum Therapeutics' Net Margin (Quarter) stood at 2612.61% in 2017, then plummeted by -288bps to 10149.79% in 2018, then plummeted by -448bps to 55621.62% in 2019.
  • Its Net Margin was 55621.62% in Q1 2019, compared to 10149.79% in Q4 2018 and 9805.12% in Q3 2018.